About Valiant Laboratories
Valiant Laboratories is a company based in Mumbai (India) founded in 1980 by Chandrakant Gogri. It operates as a B2B2C. The company has 79 employees. Valiant Laboratories offers products and services including Active Pharmaceutical Ingredients.
- Headquarter Mumbai, India
- Employees 79
- Founders Chandrakant Gogri
- Stage Public
- SectorsHealthcare
- Phone•••• ••••
- Website valiantlabs.in
- Legal Name Valiant Laboratories Ltd.
- Annual Revenue₹339 Cr
FY 2023 · +61% YoY
- Net Profit₹29.00 Cr
FY 2023 · 9% margin
- EBITDA₹39.95 Cr
FY 2023 · 12% margin
- Employee Count79
Associated legal entities of Valiant Laboratories
Valiant Laboratories operates through Valiant Laboratories Limited, a listed company (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2023) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Valiant Laboratories Limited Listed CIN L24299MH2021PLC365904 | Active | 16 Aug 2021 | Mumbai, Maharashtra | ₹339 Cr | 77 | 9 | View details |
Products & Services of Valiant Laboratories
Valiant Laboratories offers a comprehensive portfolio of products and services, including Active Pharmaceutical Ingredients.
Active pharmaceutical ingredients are manufactured for medicinal use.
Board of directors of Valiant Laboratories Limited (Valiant Laboratories)
Valiant Laboratories Limited is the primary company behind Valiant Laboratories. The board of Valiant Laboratories Limited currently have 7 directors; the longest-serving is Santosh Shantilal Vora, appointed in 2021. 2 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Santosh Shantilal Vora DIN 07633923 | Managing Director | 16 Aug 2021 | 5 yrs 1 mo | Valiant Laboratories Limited |
| Shantilal Shivji Vora DIN 07633852 | Director | 16 Aug 2021 | 5 yrs 1 mo | Valiant Laboratories Limited |
| Paresh Shashikant Shah DIN 08291953 | Whole-time director | 16 Aug 2021 | 5 yrs 1 mo | Valiant Laboratories Limited |
| Sonal Amit Vira DIN 09505883 | Director | 16 Feb 2022 | 4 yrs 7 mo | Valiant Laboratories Limited |
| Sandeep Gupta DIN 09245060 | Director | 23 Feb 2023 | 3 yrs 7 mo | Valiant Laboratories Limited |
| Mulesh Manilal Savla DIN 07474847 | Director | 14 May 2024 | 2 yrs 4 mo | Valiant Laboratories Limited |
| Ashok Lakhamshi Chheda DIN 10776571 | Director | 12 Nov 2024 | 1 yr 10 mo | Valiant Laboratories Limited |
People of Valiant Laboratories
1 people are tracked at Valiant Laboratories (1 in leadership); the tracked headcount is 79.
| Name | Role | Group |
|---|---|---|
Chandrakant Gogri | Founder | Leadership |
Complete people profiles for Valiant Laboratories
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Valiant Laboratories
Valiant Laboratories is a publicly listed company on the NSE with ticker symbol VALIANTLAB in India, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date06 Oct 2023
- Listed onBSE: 543998 · NSE: VALIANTLAB
- Listed entityValiant Laboratories Ltd.
- Exchange sectorHealth technology
- ISININE0JWS01017
- Share price₹119.80 (+2.1% on the day) · 2026-10-09
- Market capitalisation₹651 Cr
- Price to earnings40.6
- EPS (diluted, trailing year)₹2.95
- Volume (last session)57,995
Financials of Valiant Laboratories
Figures of Valiant Laboratories Limited, the primary company behind Valiant Laboratories, for FY 2023. Revenue was ₹339 Cr (+61% year on year). Net profit was ₹29.00 Cr (9% margin). EBITDA was ₹39.95 Cr (12% margin).
- ₹339 CrRevenue · FY 2023 · +61% YoY
- ₹29.00 CrNet profit · 9% margin
- ₹39.95 CrEBITDA · 12% margin
- ₹54.31 CrPaid-up capital
- 77Employees (provident fund records)
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | ₹237 Cr | -₹3.3 Cr | ₹6.6 Cr |
| 2024 | ₹133 Cr | -₹2.2 Cr | -₹1.2 Cr |
| 2023 | ₹182 Cr | ₹0.3 Cr | -₹7.7 Cr |
| 2022 | ₹334 Cr | ₹29.0 Cr | ₹35.7 Cr |
| 2021 | ₹292 Cr | ₹27.5 Cr | ₹42.3 Cr |
Balance sheet, profit and loss, cash flow and ratios of Valiant Laboratories Limited are on its company page.
Detailed financial statements for Valiant Laboratories
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Web traffic of Valiant Laboratories
The website of Valiant Laboratories (valiantlabs.in) receives about 2.4K visits a month.
- Monthly visits2.4K
▼ 62.4% vs previous month
Latest news on Valiant Laboratories
Complete news archive for Valiant Laboratories
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Valiant Laboratories
10 companies that operate in the same segment as Valiant Laboratories (Traditional Health & Nutrition), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Manufacturer of generics formulations | 2002 | Bridgewater, New Jersey, United States | – | USD 3.02 B | 8,300 | |
Biosimilar therapeutics are developed for oncology and autoimmune diseases. | 2010 | Redwood City, California, United States | USD 143.62 M | USD 42.17 M | 228 | |
Oral solid drug delivery systems are manufactured and developed. | 1985 | Mumbai, Maharashtra, India | USD 42.49 M | USD 89.42 M | 962 | |
Ophthalmic pharmaceuticals and instruments are developed for eye care. | 1853 | Bridgewater, New Jersey, United States | – | USD 5.1 B | 13,500 | |
Generic pharmaceuticals are manufactured by Teva Pharmaceuticals. | 1901 | Petah Tikva, Central District, Israel | USD 500 M | USD 18.74 B | 51,792 | |
Generic, semi-solid, and liquid dosage forms are manufactured. | 1990 | Bengaluru, Karnataka, India | – | USD 508.93 M | 5,180 | |
Pharmaceutical products are developed and marketed globally. | 2009 | Montville, New Jersey, United States | USD 155.92 M | – | – | |
Specialty generic pharmaceuticals and APIs are manufactured and marketed. | 1983 | Mumbai, Maharashtra, India | – | USD 6.21 B | 25,870 | |
Pharmaceutical company engaged in developing, manufacturing, and marketing a diverse range of pharmaceutical formulations | 1991 | Delhi, Delhi, India | USD 367.2 M | USD 1.52 B | 21,320 | |
Generics, biosimilars, APIs, and vaccines are manufactured by Wockhardt. | 1967 | Mumbai, Maharashtra, India | – | USD 353.53 M | 3,410 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Valiant Laboratories
Valiant Laboratories was founded in 1980.
Valiant Laboratories is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Valiant Laboratories has 79 employees.
The primary company behind Valiant Laboratories, Valiant Laboratories Limited, reported revenue of ₹339 Cr for FY 2023, up 61% year on year.
Valiant Laboratories Limited is involved in the production of active pharmaceutical ingredients for the healthcare sector in India. The company, part of the Aarti Group of Industries, has built a reputation over 40 years as a reliable supplier. Operations are focused on meeting and anticipating market demands in the pharmaceutical industry. A specialized business model and deep domain knowledge are utilized to achieve sustainable growth and profitability.
Valiant Laboratories offers Active Pharmaceutical Ingredients.
Yes, Valiant Laboratories is publicly traded on NSE under the ticker symbol VALIANTLAB.
Valiant Laboratories operates through Valiant Laboratories Limited.
The legal entities of Valiant Laboratories currently have 8 directors, including Santosh Shantilal Vora, Shantilal Shivji Vora, Paresh Shashikant Shah and others.